Chris Howerton joined Jefferies in April of 2014 as part of the Biotechnology equity research team covering small/mid-cap names. Prior to Jefferies, he headed the Microbiome Discovery Platform at Assembly Biosciences. Chris’s academic training includes post-doctoral research fellow in Neuroscience at both Stanford University and the University of Pennsylvania and he received a BS in Animal Science, a MS in Animal Biology and a PhD in Behavioral Sciences, all from the University of California, Davis.